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Abstract
Numerous publications are devoted to different aspects of genital herpes (GH) in pregnant women, to its negative influence over the development 
of gestation period and the high incidence of perinatal mortality and morbidity. At the same time, the opinions over the administration of antiviral 
treatment in pregnant women, is controversial.  The study purpose: To evaluate the efficacy of treatment of GH infection with Valtrex in pregnant women. 
Material and method: A retrospective study done during the years 2008-2009.  he entire group of 70 pregnant women, included in the research, suffered 
from GH during their pregnancy period. The group was divided into 2 groups, group I - which received antiviral treatment and group II - which did not 
receive any antiviral treatment.  Results and discussions: The pregnant women who have not received antiviral treatment, compared to the group I, had 
a higher level of recurrent miscarriages, premature births, oligo- and polihidramnios, fetal growth retardation and placental insufficiency. In group II, 
11.2% of early neonatal newborns died, the rate of neonatal morbidity reached up to 54.6%, compared to group I, where there were no neonatal deaths 
and the perinatal morbidity rate is of 10.5%.  The study, on children who were born by the mothers infected with genital herpes and who did not received 
any treatment during pregnancy, has allowed us to determine 20.3% cases of neurological pathologies, compared with group I, where we had just 3.5% 
cases.  Conclusions: The high incidence of the recurrent miscarriages, perinatal mortality and morbidity, the neurologic sequelae in children who were 
born by women who have had GH infection during their pregnancy and did not receive any etiological treatment, allow us to advise the administration 
of Valtrex in antiviral treatment during pregnancy.
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Эфективность Валтрекса у беременных с генитальным герпесом
Многочисленные публикации посвящены различным аспектам беременности у женщин с генитальным герпесом, который имеет негативное 
влияние на развитие беременности, с высоким уровнем перинатальной смертности и заболеваемости.  Мнение о назначении противовирусного 
лечения у беременных не однозначно.  Цель: Эффективность лечения Валтрексом генитального герпеса у беременных.  Материал и методы: 
Ретроспективное исследование в течение 2008-2009 года.  Исследуемая группа из 70 беременных делится на две группы: I – с использованием 
противовирусного препарата Валтрекс и II – без лечения генитального герпеса.  Результаты и обсуждение: У беременных, которые не 
получали противовирусное лечение был высокий уровень репродуктивных потерь, преждевременных родов, мало- и многоводие, синдром 
задержки роста плода и плацентарной недостаточности, по сравнению с I группой.  Во II группе 11,2% новорожденных родились мертвыми, 
неонатальная заболеваемость достигла 54,6%, по сравнению с I группой, где отсутствует гибель плода и перинатальная заболеваемость составляет 
10,5%.  Дистанционное исследование детей, рожденных у матерей с генитальным герпесом, которые не получали никакого лечения во время 
беременности, позволило определить неврологические заболевания в 20,3% случаев, по сравнению с I группой в 3,5% случаев.  Выводы: 
Высокий уровень репродуктивных потерь, перинатальной смертности и заболеваемости, неврологические осложнения у детей, мамы которых 
не получали этиологического лечения, позволяют рекомендовать назначение противовирусной терапии Валтрексом во время беременности.
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Introduction
The herpes virus infectious pathology is a stringent 
problem of contemporary obstetrics being first placed in the 
perinatal morbidity and mortality structure.
The rates of maternal-fetal transmission of herpes simplex 
virus (HSV) in pregnant women with primary and recurrent 
herpes infection, is of 1.4 to 32% cases [1, 2].  In most cases, 
the fetus is infected during maternal viremia, via the trans-
placental passage of the HSV or via continually increasing 
cervical secretions throughout the entire gestation period. 
The fetal viremiа will appear within 2-3 weeks after the infec-
tion, and then it will be followed by viruri and viramnia.  If 
the transplacental infection occurs within the first 20 weeks of 
gestation, then in 34% cases they end up in miscarriages.  If it 
occurs within the first 20-34 weeks, then 30% of pregnancies 
get complicated and end up in antenatal fetal death, premature 
birth, and neurological diseases.  More severe consequences 
occur when the infection happens within the first half of 
pregnancy, involving the central nervous system of the fetus, 
manifested by mental retardation, spastic quadriplegia and 
eye disorders [3, 4].  The ascending infection of the cervix 
is associated with the reproduction and accumulation of the 
virus in amniotic fluid and is manifested by polyhydramnios, 
intrauterine growth retardation, edema syndrome, prematu-
rity, however the fetus is less affected than the transplancental 
infection.  When the herpes outbreaks are present at per the 
via naturalis birth, the infection occurs through the superficial 
bruising, fetal conjunctivitis, absorption of amniotic fluids, 
and the penetration at the lung level causes atypical pneumo-
nia.  Due to HSV trophism of the nervous tissue, the infection 
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of the fetus can result in the occurrence of the hydrocephalus, 
microcephaly, ventricular expansion and gray matter atrophy 
[5, 6].  The innate herpes infection in the fetus has an inci-
dence of one case in 5-10000 births, but the mortality in this 
group reaches 70%.  At the same time, the surviving children 
suffer from severe neurological consequences.  In the U.S. 
around 400 to 1000 children are born annually with inborn 
herpes infection, out of which just 15% remain healthy [7, 8, 
9].  Currently, the target in the herpes infection treatment, in 
pregnant women, is reducing the disease’s severity; to decrease 
the infectivity and the complications risk by inhibiting of viral 
replication, to stop the infection spreading, to prevent the 
intrauterine, intranatal and postnatal infection of the fetus. 
The majority of the antiviral products used in the therapy 
of the infections caused by herpesviruses act by inhibiting 
the synthesis of the viral DNA which are, from the chemical 
point of view, the nucleoside analogues of the purines and 
pyrimidines bases.
The most-used compounds in the treatment of infections 
caused by herpes viruses are acyclovir and its analogues - 
valacyclovir and gancyclovir.  The recommended antiviral 
medications, in herpes infection, are the Valtrex pills, which 
is an L-valine ester of Acyclovir.  In order for the acyclovir to 
become active it should be phosphorylased with the help of the 
thymidine kinase.  The monophosphate is further converted 
into guanylate diphosphate kinase, and afterwards, by a num-
ber of cellular enzymes, is converted into triphosphate.  The 
Aciclovir triphosphate interferes with the viral polymerase 
DNA and inhibits the DNA’s replication.  The Aciclovir is not 
toxic because the healthy cells cannot use it and the human 
DNA polymerase is not sensitive to acyclovir.
The aim of this study was to evaluate the efficacy of treat-
ment with Valtrex of GH infection in pregnant women.
Material and methods
The study was conducted within the period 2008 -2009, 
in the Municipal Clinical Hospital No. 1 from Chisinau, 
being one of a clinical controlled kind, in a group of 70 
pregnant women diagnosed with recurrent genital herpes 
in the period of their pregnancy.  The herpes infection was 
diagnosed by the presence of the characteristic outbreaks 
on the vulva, vagina and cervix, positive serological re-
actions in HSV, assessed by PCR and IgM.  The patients 
included in the study were divided into two groups: I - 35 
pregnant women who received antiviral treatment with 500 
mg Valtrex, twice a day for 5 days, initiated from the 16th 
week of gestation at each spurt of herpes reactivation, and 
group II - 35 pregnant women who received no treatment 
for various reasons.  It also was studied and the psychomo-
tor development in children < 1 year of age, whose mothers 
suffered of herpes infection during pregnancy.
All the data were entered into an electronic database 
using Epi Info software, version 3.3.2 (2005).  In order to 
estimate the significance threshold, it was calculated the 
T-Student test, the confidence interval and the significance 
threshold.
Results
The average age of pregnant women included in the study 
ranged between 18 and 41 years of age, the average being 29.6 
± 1.9 years of age.  Among the pregnant women, included in 
the study, we recorded: primiparous - 61.9 ± 5.81% cases, and 
multiparous - 38.1 ± 5.42% cases.  The complicated obstetric 
anamnesis was found in 45.6 ± 5.95% of cases, including: 34.2 
± 5.67% had a history of medical abortions anemnesis, 62.1 
± 5.79% - spontaneous abortions, 12.7 ± 3.98% - stagnated 
pregnancies and 14.8 ± 4.24% - premature births.
Analyzing the obtained data, based on the herpes reacti-
vation form, we found that in each second pregnant woman 
(54.5 ± 5.95% of cases) we had, a mild form of 1-2 reactiva-
tions per year, 23.1 ± 5.04% cases of an average form of 3-4 
reactivations per year, and a serious form in 4.6 ± 2.50% (5 
and more reactivations per year) of cases.
In the structure of the extra genital pathologies, the pre-
dominant diseases are the ones of the urinary system, of 51.2 
± 5.97% cases, iron deficiency anemia - 35.9 ± 5.73% cases, 
pathology in the endocin system - 20,3 ± 5,26% cases, but, 
from the statistic point of view, we didn’t find any significant 
differences.  In the group I, during pregnancy, we found im-
minent abortion in 16.8 ± 4.47% of cases, compared to group 
II - 47.8 ± 5.97% cases (p < 0.001).  In group I, the pregnancy-
induced hypertension was recorded in 19.1 ± 4.69% cases, in 
group II - 23.1 ± 5.04% (p > 0.05) cases.
After the ultrasound examination (USG) of the pregnant 
women included in the study, the pathology of the feto-pla-
cental system was diagnosed in 25.9 ± 5.24% cases, for group 
I - 8.3± 3.29% (p < 0.05), and group II -17.4 ± 4.53% of cases, 
the majority rate is taken by the feto-placental insufficiency, 
in the group I where we recorded 5 ± 3.15% cases, while in 
group II - 7.5 ± 3.15% cases, fetal hypotrophy- in group I we 
recorded 3.5 ± 2.19% cases and in group II - 11.2 ± 3.37% 
cases, the polyhydramnios was found in group I – 3.5 ± 2.19% 
cases and in group II - 9.2 ± 3.31% cases, oligoamniosis was 
diagnosed in 0.0% cases in group I, and in group II in 11.2 
± 3.37% cases.
If we look at the way the pregnancy resulted in pregnant 
women from group II, we can see that they ended with: 3 cases 
of early miscarriage (7.5 ± 3.15%), 1 case of a late miscarriage 
(3.5 ± 2.19%), 2 cases stopped during their development (7.5 
± 3.15%), 1 case of antenatal fetal death (3.5 ± 2.19%), 2 cases 
of premature birth (7.5 ± 3.15%), comparing to the group I 
there was only one case (3.5 ± 2.19%) of early miscarriage and 
one case (3.5% ± 2.19%) of preterm.
Analyzing the way the pregnancies ended, we observed the 
following results: 81.4 ± 1.6% of pregnant women, infected 
with genital herpes, gave births per vias naturalis, for 18.6 
± 3.2% cases there was done caesarean section, because the 
presence of herpes outbreaks starting from the 36th week of 
gestation, or the onset of labor with the presence of outbreaks 
on the cervix, vagina and vulva in the intact fetal membrane.
According to the data obtained from the study, the prenatal 
rupture of the amniotic membrane occurred in 12.5 ± 3.95% 
cases in group I, and in 32.6 ± 5.60% cases in group II.  An 
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alkydiene period which was longer than 18 hours was present 
in 8.7 ± 3.37% parturients in group I, and in 36.9 ± 5.77% in 
group II.  The birth distocies in pregnant women infected 
with herpes were present for 4.2% ± 2.39% cases in group I, 
and 12.3 ± 3.93% in group II.  The acute hypoxia of the fetus 
was estimated in 9.2 ± 3.45% cases in group I, and in 35.6 ± 
5.72% cases in group II (p < 0.001).
Compared to the group II, where from all the pregnant 
women infected with genital herpes, they gave birth to alive 
newborn babies in 66 (89.5 ± 3.66%) cases, and in 4 (10.5 ± 
3.77%) cases the babies were born dead, in group I, all the 
newborn babies were born alive (p < 0.05).
Assessing the Apgar newborns score after 1 and 5 minutes: 
in group I, we found less than 6 points- 2 cases and in group 
II - 6 cases, PR = 0.88, 7 points in group I -7 cases and in 
group II -9 cases, PR = 0.59, 8 points in group I - 18 cases and 
in group II -25 cases, PR = 0.42, 9 points in group I-1 case in 
group II - 0 cases, PR = 0.0.
We measured the weight of the neonates, with the average 
of 2960.3 ± 124.1 gr. A first degree of intrauterine fetal growth 
retardation was found in: group I - 16.5 ± 4.44% cases, in 
group II - 43.5 ± 5.43% cases (p < 0.05), 2nd degree in: group 
I - 4.4 ± 2.45% cases, and in group II - 24.6 ± 5.15% cases (p < 
0.01), and 3rd grade: in group II - 4.1 ± 2.37% cases (p > 0.05).
Assessing the newborns from both groups we determined, 
that 4 early neonatal (11.2 ± 3.37%) newborns from the group 
which did not receive any treatment, died.  At the morphopa-
thological examination were diagnosed such pathologies as 
meningoencephalitis, neonatal sepsis, generalized peritonitis.
We had 3.5 ± 2.19% cases of conjunctivitis, 9.2 ± 3.31% 
cases of spasms, and 20.0 ± 4.81% cases of viral pneumonia. 
At the USG in the 3rd day after the postpartum, we had 7 cases 
(20.0 ± 4.81%) of newborns with ventriculomegaly.  We did 
not have any baby death in group I, 2 (5.7 ± 2.77%) newborn 
babies suffered from viral pneumonia, and we had 1 (3.5 ± 
2.19%) case of ventriculomegaly.
The result obtained for children born by mothers with 
genital herpes who received no treatment during pregnancy 
has allowed us to determine: 2 (5.7 ± 2.77%) cases of hydro-
cephalalgia, 4 (11.2 ± 3.77%) cases of epilepsy, and 2 (5.7 ± 
2.77%) cases of  retarded psychomotor development, compari-
ng with those from group I, where there were no neurological 
pathologies (p < 0.05).
Conclusions and discussions
The study results show that the pregnancy in women 
with untreated herpes infection ended up with 6 times more 
frequently reproductive miscarriages than for the ones from 
the group who received treatment.  In the group II, we had 
3 times the frequency of fetoplacental pathology and of am-
niotic fluid were found in the and 3 times more frequently 
than in group I.
The analysis of the obtained results allowed us to empha-
size that the births where the parturients were infected with 
herpes and did not receive antiviral treatment were com-
plicated by the prenatal rupture of the amniotic membrane 
four times more frequently than for the ones who received 
antiviral treatment.
The children from mothers with untreated GH suffer from 
various pathologies, especially neurological ones both in the 
neonatal period and during the first year of life.
In the case of herpetic infection, the optimal way of birth, 
must be determined by the clinical form of the genital herpes, 
confirmed by the presence of rash on the labia, vagina and 
cervix and positive serological reactions to HSV- 1 and 2 
(PCR or IgM).
The high levels of perinatal mortality and morbidity in 
group II, delayed neurological sequelae in children whose 
mothers suffered genital herpes in pregnancy and received no 
etiologic treatment, allow us to recommend the administra-
tion of antiviral treatment, with Valtrex, in pregnancy, which 
has to be initiated as early as possible, for every spurt of the 
herpetic reactivation, after 16 weeks of gestation.
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